- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04455919
Yoga for Chronic Chikungunya (YOCHIK)
Impact of Yoga on Quality of Life in Patients With Chronic Chikungunya: A Randomized Controlled Study
The purpose of this study is to assess the benefits of a 8-week yoga program on quality of life in patients suffering from chronic chikungunya.
Studies have already shown the effectiveness of yoga practice on various arthralgia's, on the reduction of inflammatory reactions, on psychological disorders/sleep disorders and on quality of life. Considering quality of life as a global experience of balance between physical and mental wellbeing, the hypothesis was that the practice of yoga would globally improve the quality of life of patients with chronic chikungunya.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The chikungunya virus (CHIKV) is an arbovirus passed to humans by Aedes mosquitoes. Since its description in 1952, CHIKV has caused millions of human infections in Africa, the Indian Ocean islands, Asia, Europe and America (1). In total, since 2013, the epidemic has affected more than 2 million people in the Americas. In Guadeloupe, the emergence of chikungunya cases began in 2013. CHINKV was declared an epidemic in 2014 with an estimated 20,000 infected patients.Human infection with CHIKV is characterized by a sudden onset of severe joint pains, high fever and rash. The infection is self-limited and acute symptoms usually disappear within one or two weeks. However, this polyarthralgia is recurrent in 30 to 40% of infected people and can persist for years. Chikungunya is considered chronic if the symptoms persist after three months. The chronic stage can last from a few months to several years. Chronic chikungunya usually manifests as joint pain and stiffness, polyarthralgia (including rheumatoid arthritis, flare-ups of spondylitis), and other general symptoms such as intermittent headaches, edema, and paresthesia. The consequences of chronic CHIKV can be severe, with patients becoming maladjusted to their lifestyle, feeling weakened and diminished. Depression and medical leaves are very frequent, with many cases of disability. Yoga is an ancestral Indian practice aiming to connect the "body" and the "soul", the "self" and "the other". Traditionally, it is a philosophical way of living, sometimes combined with the practice of physical exercises. In westernized countries, Yoga is usually considered as a physical practice or an alternative therapy, using various techniques of breathing, relaxation and poses to release tensions and decrease pain.
Studies have already shown the effectiveness of yoga practice on various arthralgia's, on the reduction of inflammatory reactions, on psychological disorders/sleep disorders and on quality of life. Considering quality of life as a global experience of balance between physical and mental wellbeing, the hypothesis was that the practice of yoga, by improving these different aspects, would globally improve the quality of life of patients with chronic chikungunya.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Pointe-à-Pitre, Guadeloupe, 97159
- Mouffias' Medical Center in Guadeloupe.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients suffering from chronic chikungunya, as documented by a positive chikungunya serology and the following symptoms: polyarthralgia and/or musculoskeletal disorder and/or morning stiffness.
- Patients had to be between 18 and 70 years old, and be
- patients affiliated to the French social insurance.
Exclusion Criteria:
- being pregnant;
- suffering from pre-existing rheumatic diseases before the Chikungunya infection;
- showing acute symptoms of a Chikungunya infection (documented serology);
- being unable to practice yoga poses ; having been recently treated with methotrexate or corticosteroids (less than 3 months ago);
- being under guardianship, trusteeship or legal protection,
- participating in another research study,
- showing severely impaired physical and/or psychological health, which in the opinion of the investigator, may affect the compliance of the study participant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Yoga
Yoga classes once a week for eight weeks
|
During 8 weeks, the intervention group attended weekly yoga sessions and had to practice poses at home
|
OTHER: Wait-list control
The delayed intervention group was to benefit from the intervention after week 8.
|
The wait-list group benefit from a 8-week yoga program after the interventional group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health Related Quality of Life - Short Form-36 (SF-36)
Time Frame: At baseline
|
This scale measures eight health domains (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health) of quality of life for adults aged 18 and older.
Using a scoring algorithm, the aggregated scores can provide two summary scores: the physical component summary (PCS) score and the mental component summary (MCS) score.
|
At baseline
|
Health Related Quality of Life - Short Form-36 (SF-36)
Time Frame: after 8 weeks of intervention
|
This scale measures eight health domains (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health) of quality of life for adults aged 18 and older.
Using a scoring algorithm, the aggregated scores can provide two summary scores: the physical component summary (PCS) score and the mental component summary (MCS) score.
|
after 8 weeks of intervention
|
Health Related Quality of Life - Short Form-36 (SF-36)
Time Frame: after 18 weeks
|
This scale measures eight health domains (Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health) of quality of life for adults aged 18 and older.
Using a scoring algorithm, the aggregated scores can provide two summary scores: the physical component summary (PCS) score and the mental component summary (MCS) score.
|
after 18 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
nociceptive pain - Visual Analog Scale (VAS)
Time Frame: At baseline
|
The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain).
The patient is asked to mark their current pain level on the line.
They can also be asked to mark their maximum, minimum, and average pain.
The examiner scores the VAS by measuring the distance in either centimeters (0 to 10) or millimeters (0 to 100) from the "no pain" anchor point.
|
At baseline
|
nociceptive pain - Visual Analog Scale (VAS)
Time Frame: after 8 weeks of intervention
|
The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain).
The patient is asked to mark their current pain level on the line.
They can also be asked to mark their maximum, minimum, and average pain.
The examiner scores the VAS by measuring the distance in either centimeters (0 to 10) or millimeters (0 to 100) from the "no pain" anchor point.
|
after 8 weeks of intervention
|
nociceptive pain - Visual Analog Scale (VAS)
Time Frame: after 18 weeks
|
The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain).
The patient is asked to mark their current pain level on the line.
They can also be asked to mark their maximum, minimum, and average pain.
The examiner scores the VAS by measuring the distance in either centimeters (0 to 10) or millimeters (0 to 100) from the "no pain" anchor point.
|
after 18 weeks
|
neuropathic pain- DN4 scale
Time Frame: At baseline
|
The total score is calculated as the sum of the 10 items and the cut-off value for the diagnosis of neuropathic pain is a total score of 4/10.
|
At baseline
|
neuropathic pain- DN4 scale
Time Frame: after 8 weeks of intervention
|
The total score is calculated as the sum of the 10 items and the cut-off value for the diagnosis of neuropathic pain is a total score of 4/10.
|
after 8 weeks of intervention
|
neuropathic pain- DN4 scale
Time Frame: after 18 weeks
|
The total score is calculated as the sum of the 10 items and the cut-off value for the diagnosis of neuropathic pain is a total score of 4/10.
|
after 18 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PAP/RI2/2019_05
- 2019-A01632-55 (OTHER: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chikungunya Virus Infection
-
National Institutes of Health Clinical Center (CC)CompletedDengue Virus | Zika Virus | Chikungunya Virus InfectionsUnited States
-
Valneva Austria GmbHCompletedChikungunya Virus InfectionUnited States
-
Valneva Austria GmbHCompletedChikungunya Virus InfectionUnited States
-
Centre Hospitalier Universitaire de Pointe-a-PitreUnknownChikungunya Virus InfectionFrance
-
Centre Hospitalier Universitaire de la RéunionCompletedChikungunya Virus InfectionRéunion
-
Valneva Austria GmbHActive, not recruitingChikungunya Virus InfectionUnited States
-
Themis Bioscience GmbHWalter Reed Army Institute of Research (WRAIR)CompletedChikungunya Virus InfectionPuerto Rico
-
Universidad de AntioquiaUnited States Agency for International Development (USAID); Bill and Melinda... and other collaboratorsCompletedDengue | Zika Virus Infection | Chikungunya Virus InfectionColombia
-
Bavarian NordicEmergent BioSolutionsCompletedChikungunya Virus InfectionUnited States
-
Themis Bioscience GmbHCompletedChikungunya Virus InfectionAustria, Germany
Clinical Trials on Yoga group
-
University of California, San FranciscoMount Zion Health Fund; Pritzker Family Foundation; Mental Insight FoundationCompletedDepression, UnipolarUnited States
-
University of OsloCompletedMental Health | Depression, Anxiety | Sleep Problem | Public Health | University StudentsNorway
-
Colorado State UniversityCompleted
-
Jenilee SneedWithdrawnPsychological Distress | Mindfulness
-
Region Örebro CountyCompletedDepression | Stress | Anxiety
-
Robert SaperThe Cleveland ClinicCompletedBack Pain | Chronic PainUnited States
-
Dokuz Eylul UniversitySuspendedAnkylosing Spondylitis | YogaTurkey
-
Centre for Addiction and Mental HealthCompleted
-
University of OklahomaCompleted